newsfilter
← Latest News
GlobeNewswire·

Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference

SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical